Literature DB >> 27482516

Nearing elimination of meningitis A from the African "meningitis belt" using meningococcal A conjugate vaccine.

Saurabh RamBihariLal Shrivastava1, Prateek Saurabh Shrivastava1, Jegadeesh Ramasamy2.   

Abstract

Entities:  

Year:  2016        PMID： 27482516      PMCID： PMC4956163          DOI： 10.11599/germs.2016.1091

Source DB:  PubMed          Journal:  Germs        ISSN： 2248-2997


× No keyword cloud information.
  7 in total

1.  Meningococcal meningitis: vaccination outbreak response and epidemiological changes in the African meningitis belt.

Authors:  Francisco Javier Carod Artal
Journal:  Int Health       Date:  2015-04-15       Impact factor: 2.473

2.  Microbiological and epidemiological investigation of the Neisseria meningitidis serogroup A epidemic in Niger in 2009: last wave before the introduction of the serogroup A meningococcal conjugate vaccine?

Authors:  J M Collard; Z Maman; A Abani; H B Mainasara; S Djibo; H Yacouba; R Maitournam; F Sidikou; P Nicolas; J Rocourt; J F Jusot
Journal:  Epidemiol Infect       Date:  2011-01-20       Impact factor: 2.451

3.  Meningococcal disease control in countries of the African meningitis belt, 2014.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2015-03-27

4.  A severe epidemic of meningococcal meningitis in Nigeria, 1996.

Authors:  I Mohammed; A Nasidi; A S Alkali; M A Garbati; E K Ajayi-Obe; K A Audu; A Usman; S Abdullahi
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 May-Jun       Impact factor: 2.184

5.  The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine.

Authors: 
Journal:  J Infect Dis       Date:  2015-04-09       Impact factor: 5.226

6.  Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination.

Authors:  Jean-Marc Collard; Bassira Issaka; Maman Zaneidou; Stéphane Hugonnet; Pierre Nicolas; Muhamed-Kheir Taha; Brian Greenwood; Jean-François Jusot
Journal:  BMC Infect Dis       Date:  2013-12-06       Impact factor: 3.090

7.  Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013.

Authors:  Kadidja Gamougam; Doumagoum M Daugla; Jacques Toralta; Cyriaque Ngadoua; Florence Fermon; Anne-Laure Page; Mamoudou H Djingarey; Dominique A Caugant; Olivier Manigart; Caroline L Trotter; James M Stuart; Brian M Greenwood
Journal:  Emerg Infect Dis       Date:  2015-01       Impact factor: 6.883
  7 in total
  3 in total

1.  Progress in Vaccine-Preventable and Respiratory Infectious Diseases-First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006-2015.

Authors:  Anne Schuchat; Larry J Anderson; Lance E Rodewald; Nancy J Cox; Rana Hajjeh; Mark A Pallansch; Nancy E Messonnier; Daniel B Jernigan; Melinda Wharton
Journal:  Emerg Infect Dis       Date:  2018-07       Impact factor: 6.883

2.  Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis.

Authors:  Alcides Moniz Munguambe; António Eugénio Castro Cardoso de Almeida; Aquino Albino Nhantumbo; Charlotte Elizabeth Come; Tomás Francisco Zimba; José Paulo Langa; Ivano de Filippis; Eduardo Samo Gudo
Journal:  PLoS One       Date:  2018-08-08       Impact factor: 3.240

3.  Etiology of Bacterial Meningitis Among Children <5 Years Old in Côte d'Ivoire: Findings of Hospital-based Surveillance Before and After Pneumococcal Conjugate Vaccine Introduction.

Authors:  Catherine Boni-Cisse; Sheikh Jarju; Rowan E Bancroft; Nicaise A Lepri; Hamidou Kone; N'zue Kofi; Alice Britoh-Mlan; Flore Sandrine Zaba; Effua Usuf; Peter Sylvanus Ndow; Archibald Worwui; Jason M Mwenda; Joseph N Biey; Bernard Ntsama; Brenda A Kwambana-Adams; Martin Antonio
Journal:  Clin Infect Dis       Date:  2019-09-05       Impact factor: 9.079
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.